A new wearable device may detect cancer with more precision

MARIA COHUT | April 1, 2019

article image
Researchers from the University of Michigan have developed and are now testing a device they call "the epitome of precision medicine" that detects cancer in circulating blood. "Nobody wants to have a biopsy," says Dr. Daniel Hayes, the Stuart B. Padnos, Professor of Breast Cancer Research at the University of Michigan Rogel Cancer Center in Ann Arbor. Biopsies are invasive and can be uncomfortable, yet they are currently the most accurate method of determining whether or not a person has cancer.

Spotlight

Cascadia Behavioral Healthcare

The mission of Cascadia Behavioral Healthcare is to create hope and opportunity for low income people with mental illnesses and addictions, blending innovation and determination with competence, inclusion and compassion. The heart of Cascadia is our people those we serve, our co-workers, and our community partners. Together we are focused on efficiency, committed to diversity and grounded in compassion.We are consumers, counselors, accountants, case managers, nurses, administrative support workers, doctors, and the full complement of all the people needed to bring results. For many of us this is not just a job, it’s a calling.

OTHER ARTICLES

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Merck’s Patient-Centric Clinical Trial Recruiting

Article | March 4, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | March 4, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

What do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life

Article | April 10, 2020

The president and some of his close advisors — desperate for a COVID-19 cure — are asking “What do you have to lose?” by taking hydroxychloroquine (HCQ), a strong medication never adequately tested for efficacy or safety in COVID-19 patients. The correct answer to the president’s question, which he doesn’t seem to want to hear, is that we have our lives to lose. The president acknowledges “I’m not a doctor” but this raises the question “What do doctors know about the drug recommended by the president? Most doctors are aware that HCQ can be effective for patients with malaria, arthritis or lupus. If they were to follow the president’s suggestion and prescribe it for COVID-19 patients, they would also like to know that it will benefit some of those patients, at least.

Read More

Spotlight

Cascadia Behavioral Healthcare

The mission of Cascadia Behavioral Healthcare is to create hope and opportunity for low income people with mental illnesses and addictions, blending innovation and determination with competence, inclusion and compassion. The heart of Cascadia is our people those we serve, our co-workers, and our community partners. Together we are focused on efficiency, committed to diversity and grounded in compassion.We are consumers, counselors, accountants, case managers, nurses, administrative support workers, doctors, and the full complement of all the people needed to bring results. For many of us this is not just a job, it’s a calling.

Events